Prospective Assessment of Radiotherapy-associated Cardiac Toxicity in Breast Cancer Patients: Analysis of Data 3 to 6 Years After Treatment.
From: Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina 27710, USA. robert.prosnitz@duke.edu
Cancer
- Publish Date: Oct 2007
- ISSN: 0008-543X
- Volume: 110
- Issue: 8
- Pages: 1840-50
- Medium: Print
- Language: English
- Citation (JAMA): Prosnitz Robert G, Hubbs Jessica L, Evans Elizabeth S, et al. Prospective Assessment of Radiotherapy-associated Cardiac Toxicity in Breast Cancer Patients: Analysis of Data 3 to 6 Years After Treatment.. Cancer Oct 2007;110:1840-50
Abstract
BACKGROUND: Radiation therapy (RT) to the left breast/chest wall has been linked with cardiac dysfunction. Previously, the authors identified cardiac perfusion defects in approximately 50% to 60% of patients 0.5 to 2 years post-RT. In the current study, they assessed the persistence of these defects 3 to 6 years post-RT. METHODS: From 1998 to 2006, 160 patients with left-sided breast cancer were enrolled onto an Institutional Review Board-approved, prospective study. All patients received tangential photons to the left breast/chest wall. Patients had pre-RT and serial post-RT single-photon emission computed tomography (SPECT) scans to assess changes in regional cardiac perfusion, wall motion, and ejection fraction (EF). Forty-four patients had SPECT scans 3 to 6 years post-RT and were evaluable for the current analysis. RESULTS: The overall incidence of perfusion defects at 3 years, 4 years, 5 years, and 6 years was 52% (11 of 21 patients), 71% (17 of 24 patients), 67% (12 of 18 patients), and 57% (4 of 7 patients), respectively. The rate of abnormal SPECT scans 3 to 6 years post-RT in patients who had scans at 0.5 to 2 years that were either all abnormal, intermittently abnormal, or all normal was 80%, 67%, and 63%, respectively. The incidence of wall motion abnormalities in patients with or without perfusion defects 3 to 6 years post-RT was low and did not differ statistically (17% vs 7.1%, respectively; P = .65), as was the incidence of reductions in EF of >/=5% (27% vs 36%, respectively; P = .72). CONCLUSIONS: The results from this study indicated that RT-induced perfusion defects may persist or initially may appear 3 to 6 years post-RT in a high percentage of patients. However, these defects were not associated with changes in regional wall motion or EF. Additional study will be needed to determine the clinical relevance of these defects. In the meantime, the authors believe that every effort should be made to minimize incidental irradiation of the heart while maintaining adequate coverage of target volumes.
Mesh Headings (Keywords): Adult, Aged, Aged, 80 and over, Breast Neoplasms, Female, Heart, Heart Diseases, Humans, Middle Aged, Prospective Studies, Radiation Injuries, Risk Factors, Time Factors, Tomography, Emission-Computed, Single-Photon
Check for Full Text / PubMed Unique Identifier (PMID): 17763369
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.